FDA Launches Human Foods ProgramFDA Launches Human Foods Program
The program’s modernization efforts include restructuring and renaming the field operations unit to focus on inspections, investigations, and imports as its core mission.

The US Food & Drug Administration has announced the unified Human Foods Program, a new model for field operations and other modernization efforts, is now in effect.
This is the largest reorganization in the agency's modern history and impacts more than 8,000 employees and touches almost every facet of the FDA. The agency worked on the program and received helpful feedback from FDA staff and external organizations for the last year and a half.
The Human Foods Program allows FDA to most effectively deliver on its mission to protect and promote public health through science-based approaches to prevent foodborne illness, reduce diet-related chronic disease, and ensure the safety of chemicals in our food. This, FDA states, will enable them to zero in on those issues where intervention has the greatest opportunity for the prevention of disease and for the promotion of wellness.
An important part of this reorganization also includes restructuring and renaming FDA’s field operations unit to focus on inspections, investigations, and imports as its core mission. Restructuring the Office of Inspections and Investigations, formerly known as the Office of Regulatory Affairs, extends beyond foods and has an impact on how the FDA oversees all FDA-regulated products.
FDA created the enterprise-wide structure to enhance collaboration between field investigators and other subject matter experts throughout the agency, as well as modernize and strengthen the entire agency to work more cohesively and collaboratively in accomplishing its public health mission.
Another new part of the modernization efforts is a pilot of a new online consumer complaint form to both improve the consumer experience when submitting complaints as well as internally handle complaints more efficiently and effectively, helping the FDA to better detect and respond to emerging public health risks.
About the Author
You May Also Like